Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer [Phase 3]
A Phase 3 trial comparing medial vs entire supraclavicular lymph node radiation therapy in invasive breast cancer is actively recruiting.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 [NA]
A completed clinical trial evaluating estrogen levels in premenopausal women with breast cancer undergoing triptorelin and tamoxifen or exem…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer [NA]
Clinical trial update on MR-guided high-intensity focused ultrasound for ablation of breast cancer (invasive ductal carcinoma) has been term…
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating alpelisib, fulvestrant, and dapagliflozin for HR+, HER2-, PIK3CA-mutant metastatic breast cancer. Status i…
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: ModraDoc006/r in Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial update for ModraDoc006/r in metastatic and recurrent breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial investigating palbociclib with either letrozole or fulvestrant in estrogen receptor-positive, HER2-negative metastatic breast …
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients [Phase 1]
Phase 1 trial evaluating autologous breast cancer cells engineered to secrete GM-CSF in metastatic breast cancer; completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib in combination with letrozole for HER2-positive, ER-positive metastatic breast cancer; status is currentl…
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant trastuzumab, pyrotinib plus palbociclib and fulvestrant in HER2-positive, ER-positive breast c…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating Ra-223 dichloride in combination with hormonal therapy and denosumab in hormone-positive bone-dominant metastatic b…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer [Phase 3]
Phase 3 trial update on anastrozole for preventing breast cancer in postmenopausal women at increased risk.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07
Clinical trial update assessing changes in estrogen levels and grip strength in postmenopausal women on letrozole after 4-6 years of hormone…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer [Phase 1, Phase 2]
A two-phase clinical trial evaluating BYL719 (alpelisib) with nab-paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating tamoxifen citrate or Z-Endoxifen hydrochloride in locally advanced or metastatic estrogen receptor-positive, HER2-n…
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy [Phase 2]
Phase II trial comparing venetoclax plus fulvestrant versus fulvestrant alone in ER+/HER2-negative locally advanced or metastatic breast can…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer [NA]
A terminated clinical trial investigating how gut microbiome and gastrointestinal toxicities influence response to neoadjuvant chemotherapy …
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer [Phase 2]
Phase 2 trial comparing neoadjuvant everolimus plus letrozole to FEC in ER-positive, HER2-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA [Phase 3]
A Phase 3 clinical trial evaluating transversus abdominis plane (TAP) block in microsurgical breast reconstruction with abdominal free flap …
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women [Phase 2]
Phase 2 trial update exploring metformin in combination with an aromatase inhibitor for obese postmenopausal breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 [Phase 2]
Phase 2 neoadjuvant trial comparing eribulin followed by FAC versus paclitaxel followed by FEC in early-stage HER2-negative breast cancer; t…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel [Phase 2]
Phase 2 neoadjuvant trial comparing TDM1 with lapatinib and Abraxane versus trastuzumab with pertuzumab and paclitaxel in breast cancer; stu…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating genotype/phenotype-guided supplementation of tamoxifen with endoxifen in breast cancer and DCIS patients has comple…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Ibrance Real World Insights
A real-world evidence study of palbociclib (Ibrance) in breast cancer has completed and posted results as of September 17, 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating HS-10342 in Chinese patients with HR+/HER2- advanced and/or metastatic breast cancer is in the study pha…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating biomarkers associated with response to subsequent therapies in HER2-positive metastatic breast cancer; study termin…